Navigation Links
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Date:7/7/2009

ome Systems Collaborate to Develop Prostate Cancer Test Using Semen II-83 Valera and Spepharm Partner to Market Vantas, and Supprelin-LA II-84 SurModics and AbbeyMoor Collaborate to Develop Products to Treat Prostate Diseases II-84 Dendreon Constructs Manufacturing Facility in New Jersey II-84 MediGene Introduces Prostate Cancer Drug in Italian Market II-85 Gen-Probe Introduces Innovative Test for Prostate Cancer in Europe II-85 DRL Introduces Generic Version of Proscar II-85 Ferring Partners with Astellas on Degarelix License for Prostate Cancer Treatment II-85 Protox Acquires PRX321 Cancer Program from US Public Health Service and Neurocrine II-86 Astex Collaborates with CRT and Newcastle University for New Drug Discovery II-86 Miraculins and Duke University Enter into Collaboration II-86 Bayer Receives Rights to Prostate Cancer and Transplantation Drug Test from Abbott II-86 Encorium Group Signs Contract with Global Biopharmaceutical Company II-86 Paladin Signs an Agreement with Watson for Supply and Sale of Trelstar(R) II-87 BioWa Obtains License for Anti-FGF8 Antibody from Kyowa Hakko II-87 OncoGenex and Isis Pharmaceuticals Expand Partnership II-87 Caprion and AstraZeneca Enter into Collaboration II-88 Innovate Oncology and Prostagenics Enter into Capridine-Beta Development Agreement II-88 Protein Design Labs Sublicenses Antibody-Drug Conjugates Development Rights to Genentech II-88 National Cancer Institute Enters into Agreement with Illumina II-89 Sosei Seeks Marketing Rights for Prostate Cancer Drug in Japan II-89 8. Focus on Select Global Players II-90 Abbott Laboratories (USA) II-90 Aeterna Zentaris Inc. II-90 ALZA Corporation (USA) II-90 Amgen Inc. (USA) II-91 AstraZeneca PLC (UK) II-91 Medimmune, LLC (USA) II-92 Bristol-Myers Squibb Company (USA) II-92 Ce
'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... September 18, 2014 A novel robotic ... MRI scanner is currently being tested as part of ... Hospital in Boston with the aim of determining if ... make prostate cancer biopsies faster, more accurate, less costly, ... also has the potential to deliver prostate cancer therapies ...
(Date:9/18/2014)... , September 18, 2014 ... ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has announced the ... - Global Strategic Business Report" ... http://photos.prnewswire.com/prnh/20130307/600769) ,This report analyzes the worldwide ... Million by the following Product Segments: ...
(Date:9/18/2014)... On Tuesday, Secretary of Energy Ernest ... for National Lab Day on the Hill. The event ... laboratory system. Durbin and Risch also formally launched the ... of the reach of the national labs as leaders ... some of our nation's most pressing challenges. , "The ...
(Date:9/18/2014)... Sept. 18, 2014 Research and ... "Global N-acetylcysteine Industry Report 2014" report ... N-acetylcysteine Industry Report 2014 is a professional and ... global N-acetylcysteine industry. The report provides ... classifications, applications and industry chain structure. The N-acetylcysteine ...
Breaking Biology Technology:Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 3Global N-acetylcysteine Industry Report 2014 2
... Life ... Science Companies, ... Trade Zone (FTZ) Service targeting pharmaceutical and,biotechnology companies engaged in ... and creates significant,financial advantages and supply chain efficiencies for life ...
... Nussberger, MD, Today at 9.45am (EST):, "CYT006-AngQb, a Vaccine Against Hypertension ... Reduces Early-Morning and Day-Time Blood Pressure.", The American Heart Association Publishes Today ... ... Safety and Tolerability Profile Confirmed: no, Vaccine-Related Adverse Events Reported ...
... 6 Centocor,Inc., Schering-Plough Corporation, and Mitsubishi ... one million patients have now been,treated with ... therapy worldwide. In fact, REMICADE has been ... other anti-TNF-alpha agents,combined. REMICADE was the first ...
Cached Biology Technology:Sentry Logistic Solutions Launches Foreign Trade Zone Service 2Sentry Logistic Solutions Launches Foreign Trade Zone Service 3Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 2Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 3Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 4Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 5Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 6Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 7REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 2REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 3REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 5REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 6REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 7REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 8REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 9REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 10REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 11REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 12
(Date:9/18/2014)... how many times it,s demonstrated, it,s still hard ... , But by using a signaling system called ... behavior to suit their population. In short, some ... and act accordingly. , Once the population of ... from innocuous to pathogenic, or from unhelpful to ...
(Date:9/18/2014)... in DNA, tiny strands of nucleic acid that contain ... this genetic data, our DNA is copied into RNA ... perform tasks in our cells. , Several years ... Unlike all other known RNAs, this molecule is circular, ... abundant, little has been known about how they are ...
(Date:9/18/2014)... 2014Many Americans across racial and ethnic groups describe ... on their day-to-day life, more so than other ... speech (57% of African-Americans, 49% of non-Hispanic whites, ... asked which disease or ailment is the worst ... among African-Americans followed by AIDS/HIV. Hispanics and ...
Breaking Biology News(10 mins):Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3
... Visualized Experiments) , the revolutionary scientific journal that pairs ... to announce that submissions are now open for ... This new section will enable scientists studying behavior ... video format, bringing this scientific field to new levels ...
... A team of researchers at The New York ... PhD, Director of the NYSCF Laboratory and the NYSCF ... and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research ... of induced pluripotent stem (iPS) cells called embryoid bodies, ...
... Md. (April 1, 2013)Almost four million people die each year ... combustion of biomass fuels (wood, charcoal, crop residues, and dung), ... millions who rely on such products to cook their meals, ... and middle income countries are among the hardest hit by ...
Cached Biology News:NYSCF scientists develop 3-D stem cell culture technique to better understand Alzheimer's disease 2Deadly effects of certain kinds of household air pollution lead to call for biomarker studies 2Deadly effects of certain kinds of household air pollution lead to call for biomarker studies 3
Automated Cell Culture Flask...
Cell Culture Flask, 75 cm, treated polystyrene...
... style shaker flasks have three extra deep ... solutions to improve oxygen or gas transfer ... The long neck reduces splashing and is ... wall thickness provides the proper balance between ...
... IS System is a compact analysis system for ... optics, fluidics, a controller, advanced digital signal processing ... lab analysis system includes the Luminex 100, the ... a DMF file at the FDA, and partner ...
Biology Products: